Related Experiment Video
Updated: Jan 16, 2026

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
Interleukin-17A mediates acquired immunity to pneumococcal colonization
Ying-Jie Lu1, Jane Gross, Debby Bogaert
1Department of Medicine, Division of Infectious Diseases, Children's Hospital, and Harvard Medical School, Boston, Massachusetts, United States of America.
New research reveals that interleukin-17A (IL-17A) is key to clearing pneumococcal colonization in mice and potentially humans. This immune response enhances neutrophil activity, offering a new target for pneumococcal vaccines.
Area of Science:
- Immunology
- Microbiology
- Vaccinology
Background:
- Anticapsular antibodies provide serotype-specific immunity against pneumococci, but children clear colonization before these antibodies develop.
- Previous studies showed CD4+ T cell-dependent, antibody- and serotype-independent protection against pneumococcal colonization after intranasal immunization in mice.
Purpose of the Study:
- To investigate the mechanisms behind antibody-independent pneumococcal immunity.
- To identify the role of specific cytokines and immune cells in accelerated pneumococcal clearance.
Main Methods:
- Intranasal immunization of mice with pneumococci.
- Adoptive transfer of immune CD4+ T cells into RAG1(-/-) mice.
- Analysis of cytokine knockout mice (interferon-gamma, IL-4, IL-17A receptor) and neutrophil-depleted mice.
- In vitro assessment of IL-17A expression and its effect on neutrophil-mediated bacterial killing.
Main Results:
- Immunity accelerates pneumococcal clearance rather than preventing carriage, with neutrophilic infiltration observed.
- Immune CD4+ T cells conferred protection via adoptive transfer.
- IL-17A was critical for protection; mice lacking IL-17A receptor or neutrophils were not protected.
- IL-17A expression was elevated in vaccinated mice and predicted protection.
- IL-17A enhanced pneumococcal killing by human neutrophils, independent of antibodies and complement.
Conclusions:
- Interleukin-17A (IL-17A) plays a critical role in mediating pneumococcal immunity in mice and likely humans.
- IL-17A enhances neutrophil function for bacterial clearance.
- In vitro IL-17A elicitation could inform the development of novel pneumococcal vaccines.
Related Concept Videos
Cell-mediated Immune Responses
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Pneumonia II: Pathophysiology
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

